Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 8, 1997

View Archived Issues

StressGen and Genzyme announce closing of joint venture

PLC Systems faces class action suits

Pharmacia Biotech and Amersham Life Science merger finalized

Study confirms hepatitis B vaccine efficacy

GABA-based drug for anxiety enters phase I

PLC responds to nonapproval of its Heart Laser TMR System

New HRT option from Organon

Dietary changes may pose threat to patients on oral anticoagulants

Matrix and Savage enter marketing agreement for AccuSite

Medtronic's therapy for urinary incontinence recommended for approval by FDA panel

Update on Proleukin regulatory status; Photofrin approved in Germany

First approval for Elan's Diastat

SKB reports new agents for atherosclerosis

Protein kinase C inhibitors discovered at Cephalon

Theratechnologies: Q2 1997 highlights

Aquila issued patent covering potent drug delivery agents

Tacrine analogs reported for Alzheimer's disease

Antiarthritic activity of British Biotech MMP/TNF-alpha inhibitors

Vanadium compounds for treatment of diabetes

AmBisome approved in Korea

Cantab: Q2 1997 highlights

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...